Content Status
Type
Linked Node
Treatment Adherence for individuals taking TPT
Learning ObjectivesTreatment Adherence for individuals taking TPT
H5Content
Content
Adherence to the Tuberculosis Preventive Treatment (TPT) course and treatment completion are important determinants of clinical benefit, both at individual and population levels.
- Develop a personal adherence plan with the support of the family member, caregiver or health worker as per the treatment regimen being provided.
- Treatment support and adherence monitoring will be like that of the index patient.
- Give first preference to the family member to be the treatment provider in consultation with the person.
- Use of digital platforms (tele/ video calls, 99DOTS/ MERM), counting empty blisters, refill monitoring etc., to strengthen adherence monitoring.
- Irregular or inadequate treatment reduces the protective efficacy of TPT regimen.
- Poor adherence or early cessation of TPT can potentially increase the risk of the individual developing TB including Drug-resistant Tuberculosis (DR-TB) (although not supported by existing evidence from research settings).
- It is known that the efficacy of TPT is greatest if at least 80% of the doses are taken within the duration of the regimen. The total number of doses taken is also a key determinant of the extent of TB prevention.
The criteria for completion of TPT among DR-TB contacts have been given in the table below.
DOSES | TOTAL DURATION IN MONTHS | EXPECTED NO. OF DOSES | 80% OF RECOMMENDED DOSES (DAYS) | EXTENDED TIME FOR TREATMENT COMPLETION (DAYS) (TREATMENT DURATION + 33% ADDITIONAL TIME) |
---|---|---|---|---|
6Lfx (daily) | 6 | 180 | 144 | 239 |
4R (daily) | 4 | 120 | 96 | 160 |
Resources
- Guidelines for Programmatic Management of Drug-resistant Tuberculosis in India, 2021.
- WHO Consolidated Guidelines on Tuberculosis: Module 1: Prevention: Tuberculosis Preventive Treatment, 2020.
- Latent TB Infection: Updated and Consolidated Guidelines for Programmatic Management, World Health Organization, 2018.
Kindly provide your valuable feedback on the page to the link provided HERE
Content Creator
Reviewer
- Log in to post comments